Public Involvement – News

New Chair of INVOLVE Advisory Group

We are pleased to announce that Tina Coldham has been appointed the new Chair of the INVOLVE Advisory Group, effective 1 December 2017.  For more information, please visit the INVOLVE website.

IR35 and payment for public involvement

Changes to HMRC regulations on ‘contractors and intermediaries’ have led to some institutions processing payments for involvement in research through PAYE.  INVOLVE has discussed these changes with HMRC and the Dept of Health’s Tax Advisor, and produced an agreed statement along with INVOLVE’s understanding of how these regulations might relate to payment for involvement.

You can read the document online INVOLVE statement on HMRC IR35 regulations and more can be found about IR35 regulations on the GOV.UK website, including assistance in determining the employment status of individuals and an IR35 helpline.


New Health Research Authority (HRA) Framework on health and social care research

“Health and social care research has clear benefits, but it relies on people. They give their money to fund and their time to participate in research. It crucial that in return that research is planned, regulated and conducted in a way that inspires confidence.”
Bill Davidson, Joint Head of Policy at the Health Research Authority

Regulators and government departments who promote and protect the interests of patients across the four UK nations have set out the key principles in a new UK Policy Framework for Health and Social Care Research. The 19 principles of good practice in research are for those who manage and conduct health and social research in the UK.


NHS Expo 2017

Over 5,000 delegates attended the Health and Care Innovation Expo 2017 that was held on 11th and 12th September in Manchester.

This year, the NHS Expo explored the most important developments across health and social care, including:

  1. The achievements and lessons of the New Care Models vanguard program
  2. Delivering Sustainability and Transformation Plans
  3. Building and maintaining the right structures for collaborative, prevention-focused services
  4. New digital technology solutions supporting transformation of health and care services
  5. Accelerating the uptake of successful innovations across health and social care

The Health and Care Innovation Expo 2017 highlighted the importance of a collaborative approach to medical innovation and gave an opportunity for young medical companies to interact with all the main healthcare stakeholders.

Enrico Giuliani, Neuron Guard CEO, had the opportunity to share his experience during a panel discussion about How the NIHR is accelerating technology and innovation in the NHS.

One of the key messages of this session was that the National Institute for Health Research (NIHR) and the Healthcare Technology Co-operatives (HTCs) are performing a vital task in the new environment of innovation as they are bridging the gap between prototypes and medical products, assisting companies in overcoming barriers that would be otherwise very difficult to overcome.

Since 2014, the NIHR Brain Injury HTC has been supporting Neuron Guard navigating the complex pathway from a prototype to a medical device ready for commercialisation and liaising with relevant partners and experts. The HTC’s network has been very valuable for this young, but very promising, medical company.

Enrico Giuliani presenting Neuron Guard temperature management system for brain protection at #Expo17NHS
Enrico Giuliani presenting Neuron Guard temperature management system for brain protection at #Expo17NHS

Enrico also had the opportunity to present his prototype to the Health Minister Lord O’Shaughnessy, who showed a great interest in the interactions between the NHS institutions and private companies.

 “It was a great honour to have the opportunity to present to the Health Minister, Lord O’Shaughnessy, the work we have done with the NIHR and the Brain Injury Healthcare Technology Co-operative in evolving our technology from a proof of concept stage to an advanced human prototype. Together we bridge the gap to bring this innovation to patients” – Enrico Giuliani

nhs expo

If you missed anything, you can download the slides and presentations from the Expo 2017 app and read about the key moments on the @ExpoNHS twitter page!

See you next year at the Expo 2018 (Manchester Central on 5-6 September)!

Visit Neuron Guard website to read their article on what they learned at the NHS Expo!



Registries matter!

‘National Registries of therapy-area-specific data across the whole of the NHS in England should be created and aligned with the relevant charity’. Life Sciences Industrial Strategy (2017), Sir John Bell

We are delighted to share with you the Draft UK Shunt Registry Report 2017.Picture1

This Draft Report summarizes many of the findings from the first 20 years of the UKSR.

Considerable effort has been dedicated over the past year to cleaning up the database and updating compliance with the ever-evolving national governance mechanisms. The database is now ready to be explored in more detail.

Going forwards, the UK Shunt Registry (UKSR) under the auspices of the Society of British Neurological Surgeons (SBNS) and the British CSF Group has moved during 2015-2017 from a paper-based reporting system to the ORION-based electronic reporting system that will:

  • inform patients, carers, clinicians, providers and commissioners of healthcare, regulators, and implant suppliers of the outcomes achieved in surgical interventions for ‘hydrocephalus’,
  • provide participating centres with a local reference and audit resource, including live data access and independent data for the shunt infection CQUIN measure,
  • enhance patient awareness of outcomes after surgical interventions for ‘hydrocephalus’ to better inform patient choice and patients’ quality of experience through engagement with patients and patient organisations,
  • facilitate registry-based trials, and
  • support suppliers with the routine post market surveillance of implants and provide information to clinicians, patients, hospital management/procurement and the regulatory authorities.

Please click here to read the Draft UK Shunt Registry Report 2017.


NIHR Brain Injury HTC becomes a MedTech Co-operative

We are delighted to announce that the NIHR Brain Injury Healthcare Technology Co-operative ( has been awarded core funding of £1.25 million to continue its work to drive medtech innovation for patients after an acquired brain injury for a further 5 years (2018-2023) under the new banner of a Medtech Co-operative. The announcement by Health Secretary Jeremy Hunt of £14.25 million funding to support 11 NIHR MedTech and In vitro Diagnostic Co-operatives (MICs) coincides with the publication of Sir John Bell’s Life Sciences Industrial Strategy.

Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health said:

“The funding received by the eleven NIHR MedTech and In-vitro diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in-vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”

NIHR Brain Injury MedTech Co-operative team (Left to right): Dr Peter Jarritt (Deputy Director), Talissa Gasser (Communications & Project Officer), Professor John Pickard (Honorary Director), Mita Brahmbhatt (Programme Manager), Dr Alexis Joannides (Deputy Director).
NIHR Brain Injury MedTech Co-operative team (Left to right): Dr Peter Jarritt (Deputy Director), Talissa Gasser (Communications & Project Officer), Professor John Pickard (Honorary Director), Mita Brahmbhatt (Programme Manager), Dr Alexis Joannides (Deputy Director).

Based in Cambridge, the NIHR Brain Injury MedTech Co-operative has expertise in eleven clinical theme areas – with professional leadership as shown below – reflecting the patient pathway from initial ictus to final outcome and reintegration into the community.

  • Prevention and Pre- Hospital Care (Prof. Mark Wilson, Imperial College London),
  • Neurocritical Care (Prof. David Menon),
  • Multi-Modality Monitoring (Prof. Peter Hutchinson),
  • Intracranial Dynamics and Shunt Technology (Prof. Marek Czosnyka),
  • Functional Neuroimaging/Neurophysiology (Prof. Franklin Aigbirhio),
  • Neuro-oncology (Dr. Stephen Price),
  • Paediatrics and Neuro Development (Prof. David Rowitch and Dr. Topun Austin),
  • Regenerative Neuroscience (Dr. Mark Kotter),
  • Neurorehabilitation (Prof. Valerie Pomeroy, University of East Anglia),
  • Cognition and Mental Health (Prof. Barbara Sahakian),
  • and Neuropsychological Rehabilitation (Dr. Andrew Bateman, Oliver Zangwill Centre)

These themes are underpinned by four core support activities:

  • Patient and Public Involvement (Prof. Christi Deaton);
  • MedTech Regulation and Evaluation (Dr. Peter Jarritt);
  • Clinical Informatics and Registries (Dr. Alexis Joannides);
  • and Health Economics and Eco-system Modelling (Prof. Alonso Pena, University of Milan)

The MedTech Co-operative has a UK wide remit and will work with patients and public, NHS organisations and universities, including other MedTech and In vitro Diagnostic Co-operative (MICs), research councils, charities, industry, including  SMEs and start-ups to provide a structured and systematic approach to find areas of unmet need that might be amenable to a technology-based innovation,  facilitate the generation of innovative solutions and foster the translation of viable solutions from initial concept to successful market adoption and sustainable clinical  impact.

The National Institute for Health Research (NIHR): improving the health and wealth of the nation through research.

Established by the Department of Health, the NIHR:

  • funds high quality research to improve health
  • trains and supports health researchers
  • provides world-class research facilities
  • works with the life sciences industry and charities to benefit all
  • involves patients and the public at every step